Kugler Vision Joins the AcuFocus IC-8® Lens Clinical Study for Patients with Cataracts

Lance Kugler, M.D. at Kugler
Vision in Omaha, Neb., is participating in the AcuFocus clinical
study for the IC-8 intraocular lens (IOL) designed for patients with
cataracts.

“We work with cataract patients each day and many ask if their surgery
will help them regain not only their distance vision, but also their
intermediate and near vision,” Dr.
Kugler said. “We look forward to evaluating the IC-8 lens and its
ability to provide cataract patients with an uninterrupted range of
vision.”

By the age of 65, an estimated 90% of people worldwide experience
changes to the natural crystalline lens of the eye. The lens gradually
becomes cloudy as a cataract develops, leading to blurry vision and
eventually vision loss. The only solution to a cataract is the surgical
removal of the natural lens and its replacement with an artificial lens
called an IOL. More than 25 million cataract procedures are performed
worldwide each year. The majority of patients with cataracts are treated
with a standard monofocal (single-focus) lens, which allows the patient
to have excellent far vision; however, patients remain dependent on
glasses for near and intermediate vision.

Dr. Kugler will be one of a select group of clinical investigators
across the United States for the IC-8
lens study. The IC-8 lens is a clear monofocal lens with a mini-ring
placed in the center. The mini-ring has an opening, or pinhole, designed
to increase the range of vision by extending the focus of light rays
that enter the eye. The clinical study will determine if the IC-8 lens
in one eye, when paired with a standard monofocal lens in the other eye,
will provide near and intermediate vision in addition to far vision for
cataract patients.

Kugler Vision is now enrolling patients that meet the study eligibility
criteria. Patients who comply with study commitments will be
compensated. Some basic qualifications include the following:

• At least 22 years of age.
• Have cataracts in both eyes.
• Are available, willing and able to participate in examinations and all
  follow-up study visits and appointments.

If you are interested in becoming a volunteer participant in the IC-8
lens clinical study, please contact Jolene Palmquist at Kugler Vision at
(402) 558-2211 or at [email protected].

About Kugler Vision

Kugler
Vision is a world-class refractive surgery center, making Omaha a
destination for exceptional vision correction outcomes. As a
patient-centric practice, we specialize in procedures to reduce or
eliminate reliance on glasses and contacts.

kuglervision.com
Facebook
Twitter
Instagram
17838
Burke St., Ste. 100, Omaha, NE 68118
402.558.2211

ABOUT ACUFOCUS & THE IC-8 IOL

AcuFocus, Inc., is a privately held ophthalmic medical device company
that develops and markets breakthrough technologies for the improvement
of vision. The IC-8 lens received its CE mark in 2014 and is available
in select markets across Europe and Asia. Founded in 2001, AcuFocus is
based in Irvine, Calif. For additional information about the IC-8
intraocular lens, visit www.ic8lensclinicalstudy.com
or https://www.facebook.com/ic8lensclinicalstudy.

Caution: Investigational Device. Limited by Federal (or United States)
law to investigational use.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190205005336/en/